{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T12:01:52Z","timestamp":1771848112135,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Clinical practice guidelines for esophagogastric junction cancer (EGJ GLs) were published in 2023. In order to evaluate how EGJ GLs have been adopted into clinical practice worldwide and to identify any outstanding clinical questions to be addressed in the next edition, this survey was conducted.<\/jats:p>\n               <jats:p>An electronic questionnaire was developed. The questionnaire comprised 16 questions designed to assess the adoption of the guideline. Responses were collected online. The survey was conducted by the EGJ working group of International Gastric Cancer Association (IGCA) following approval from the guideline committee of The International Society for Diseases of the Esophagus (ISDE).<\/jats:p>\n               <jats:p>As results, we received 344 valid and complete responses. 55% of respondents were from East Asia followed by Europe, Central\/South America, and Central\/West Asia. 80% of respondents recognized and followed the guidelines to some extent. There was still diversity in the extent of lymphadenectomy for EGJ cancers with an esophageal invasion of 2\u20134\u00a0cm. Although white light imaging (WLE) alone was recommended in the EGJ GLs, both WLE and image enhanced endoscopy were used in 86% of respondents. The perioperative treatment was shown to be highly diverse worldwide. While 50% of respondents provided perioperative chemotherapy, preoperative chemotherapy without adjuvant treatment and upfront surgery were still the first treatment option in 15% of respondents.<\/jats:p>\n               <jats:p>In conclusion, the current survey conducted by IGCA and ISDE identified the current standard and remaining issues of EGJ cancers.<\/jats:p>","DOI":"10.1093\/dote\/doaf071","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T19:38:07Z","timestamp":1757360287000},"source":"Crossref","is-referenced-by-count":1,"title":["Quality indicator survey of clinical practice guidelines for esophagogastric junction cancer 2023"],"prefix":"10.1093","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-2755","authenticated-orcid":false,"given":"Satoru","family":"Matsuda","sequence":"first","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4738-3697","authenticated-orcid":false,"given":"Bas","family":"Wijnhoven","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus MC Cancer Institute, Erasmus University Medical Center , Rotterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-9339","authenticated-orcid":false,"given":"Florian","family":"Lordick","sequence":"additional","affiliation":[{"name":"Department of Oncology and University Cancer Center , , Leipzig-Jena ,","place":["Germany"]},{"name":"Leipzig Leipzig University Medical Center, Comprehensive Cancer Center Central , , Leipzig-Jena ,","place":["Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Bhandari","sequence":"additional","affiliation":[{"name":"Gastroenterology, Portsmouth University Hospital NHS Trust , Hampshire ,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fenglin","family":"Liu","sequence":"additional","affiliation":[{"name":"Second Department of Gastric Surgery, Fudan University Shanghai Cancer Center , Shanghai ,","place":["China"]},{"name":"Department of Oncology, Shanghai Medical College, Fudan University , Shanghai ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-5072","authenticated-orcid":false,"given":"Ken","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital , Tokyo ,","place":["Japan"]},{"name":"Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Gotoda","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Cancer Institute Hospital Japanese Foundation for Cancer Research , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Ferri","sequence":"additional","affiliation":[{"name":"Division of Thoracic and Upper Gastrointestinal Surgery, Montreal General Hospital, McGill University Health Centre , Montreal ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hamamatsu University School of Medicine , Hamamatsu ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Kakeji","sequence":"additional","affiliation":[{"name":"Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Graduate School of Medicine , Kobe ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3495-3048","authenticated-orcid":false,"given":"Han-Kwang","family":"Yang","sequence":"additional","affiliation":[{"name":"National Cancer Center , Seoul ,","place":["South Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Kitagawa","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keio University School of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"2025101515273930500_ref1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa2503701","article-title":"Perioperative durvalumab in gastric and gastroesophageal junction cancer","volume":"393","author":"Janjigian","year":"2025","journal-title":"N Engl J Med"},{"key":"2025101515273930500_ref2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa2409408","article-title":"Perioperative chemotherapy or preoperative chemoradiotherapy in esophageal cancer","volume":"392","author":"Hoeppner","year":"2025","journal-title":"N Engl J Med"},{"key":"2025101515273930500_ref3","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znaf035","article-title":"Oesophagectomy in the east versus the west: comparison of two national audit databases","volume":"112","author":"Matsuda","year":"2025","journal-title":"Br J Surg"},{"key":"2025101515273930500_ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10120-023-01457-3","article-title":"Clinical practice guidelines for esophagogastric junction cancer: upper GI oncology summit 2023","volume":"27","author":"Kitagawa","year":"2024","journal-title":"Gastric Cancer"},{"key":"2025101515273930500_ref5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1186\/s12885-019-5761-7","article-title":"Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study","volume":"19","author":"Hagens","year":"2019","journal-title":"BMC Cancer"},{"key":"2025101515273930500_ref6","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/S0140-6736(12)60516-9","article-title":"Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial","volume":"379","author":"Biere","year":"2012","journal-title":"Lancet."},{"key":"2025101515273930500_ref7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa1805101","article-title":"Hybrid minimally invasive esophagectomy for esophageal cancer","volume":"380","author":"Mariette","year":"2019","journal-title":"N Engl J Med"},{"key":"2025101515273930500_ref8","article-title":"Survival outcomes of thoracoscopic vs open oesophagectomy for oesophageal cancer: a multicentre, open-label, randomised, controlled, phase 3 trial (JCOG1409 MONET)","author":"Takeuchi","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025101515273930500_ref9","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae143","article-title":"Multicentre randomized clinical trial on robot-assisted versus video-assisted thoracoscopic oesophagectomy (REVATE trial)","volume":"111","author":"Chao","year":"2024","journal-title":"Br J Surg"},{"key":"2025101515273930500_ref10","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet."},{"key":"2025101515273930500_ref11","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-023-02465-7","article-title":"Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial","volume":"29","author":"Shah","year":"2023","journal-title":"Nat Med"},{"key":"2025101515273930500_ref12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jjco\/hyad149","article-title":"Protocol digest of a randomized controlled adaptive phase II\/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma: Japan clinical oncology group study JCOG2203 (NEO-JPEG)","volume":"54","author":"Kita","year":"2024","journal-title":"Jpn J Clin Oncol"},{"key":"2025101515273930500_ref13","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/gutjnl-2022-327281","article-title":"Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction","volume":"71","author":"Sugano","year":"2022","journal-title":"Gut."},{"key":"2025101515273930500_ref14","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-335666","article-title":"Validation of the definition of gastro-oesophageal junctional zone: an immunohistochemical study using resected mucosal specimens","author":"Ota","year":"2025","journal-title":"Gut."}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/5\/doaf071\/64223458\/doaf071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/38\/5\/doaf071\/64223458\/doaf071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:27:48Z","timestamp":1760556468000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doaf071\/8249373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doaf071","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"value":"1120-8694","type":"print"},{"value":"1442-2050","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,9,1]]},"article-number":"doaf071"}}